BCL2 and breast carcinoma: We next showed that modelling the interactions of the BCL-2 protein family upstream of MOMP could also accurately predict sensitivity of medulloblastoma cells to cisplatin-induced apoptosis, with similar results previously observed in colorectal and breast cancer [27, 48].